SEC 13F Intelligence

Mitchell Sinkler & Starr/Pa / ABT

Mitchell Sinkler & Starr/Pa’s Abbott Laboratories Position

Does Mitchell Sinkler & Starr/Pa own Abbott Laboratories (ABT)? Yes — 21.8K shares worth $2M (+1.03% of its 13F portfolio) as of Q1 2026, down from 22.2K shares the prior filed quarter.

Position Value
$2M
Q1 2026
Shares
21.8K
% of Portfolio
+1.03%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $2MQ4 ’18Q1 ’19: $2MQ2 ’19: $2MQ3 ’19: $2MQ4 ’19: $2MQ4 ’19Q1 ’20: $2MQ2 ’20: $2MQ3 ’20: $3MQ4 ’20: $2MQ4 ’20Q1 ’21: $2MQ2 ’21: $2MQ3 ’21: $2MQ4 ’21: $17MQ4 ’21Q1 ’22: $14MQ2 ’22: $13MQ3 ’22: $11MQ4 ’22: $12MQ4 ’22Q1 ’23: $12MQ2 ’23: $13MQ3 ’23: $12MQ4 ’23: $17MQ4 ’23Q1 ’24: $12MQ2 ’24: $11MQ3 ’24: $12MQ4 ’24: $11MQ4 ’24Q1 ’25: $12MQ2 ’25: $3MQ3 ’25: $3MQ4 ’25: $3MQ4 ’25Q1 ’26: $2Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202621.8K$2M+1.03%
Q4 202522.2K$3M+1.26%
Q3 202522.4K$3M+1.35%
Q2 202522.3K$3M+1.45%
Q1 202592.5K$12M+3.43%
Q4 202498.8K$11M+2.98%
Q3 2024112.3K$12M+2.98%
Q2 2024110.6K$11M+2.85%
Q1 2024108.7K$12M+3.09%
Q4 2023155.1K$17M+3.11%
Q3 2023120.0K$12M+3.57%
Q2 2023120.4K$13M+3.72%
Q1 2023122.3K$12M+3.66%
Q4 2022112.6K$12M+3.98%
Q3 2022118.6K$11M+4.45%
Q2 2022118.9K$13M+4.75%
Q1 2022118.9K$14M+4.41%
Q4 2021117.6K$17M+4.92%
Q3 202119.3K$2M+2.06%
Q2 202119.9K$2M+2.10%
Q1 202120.1K$2M+2.34%
Q4 202022.0K$2M+2.30%
Q3 202025.6K$3M+2.83%
Q2 202025.5K$2M+2.64%
Q1 202025.2K$2M+2.60%
Q4 201924.3K$2M+2.24%
Q3 201925.2K$2M+2.70%
Q2 201928.7K$2M+2.76%
Q1 201929.0K$2M+2.68%
Q4 201832.0K$2M+2.85%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mitchell Sinkler & Starr/Pa’s full portfolio or all institutional holders of ABT.